MARSHALL WACE, LLP - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q1 2022$138,0000.0%67,432
+104.4%
0.00%–
Q4 2021$138,000–32,985–0.00%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders